Cargando…

Editorial: Advances in the medical management of infantile hemangioma

Detalles Bibliográficos
Autores principales:	Wu, Haiwei, Ji, Yi, Zheng, Jiawei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313331/ https://www.ncbi.nlm.nih.gov/pubmed/37397362 http://dx.doi.org/10.3389/fonc.2023.1229197

Ejemplares similares

Management of infantile hemangiomas: Recent advances
por: Xu, Wei, et al.
Publicado: (2022)

Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas
por: Wu, Hai Wei, et al.
Publicado: (2018)

Integrated nontargeted and targeted metabolomics analyses amino acids metabolism in infantile hemangioma
por: Yang, Kaiying, et al.
Publicado: (2023)

Management of Infantile Hemangiomas
por: Reddy, Kavitha K
Publicado: (2014)

Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma
por: Wu, Hai Wei, et al.
Publicado: (2017)

Analysis of Therapeutic Decisions for Infantile Hemangiomas: A Prospective Study Comparing the Hemangioma Severity Scale with the Infantile Hemangioma Referral Score
por: Qiu, Tong, et al.
Publicado: (2022)

Current perspectives on the optimal management of infantile hemangioma
por: Grzesik, Peter, et al.
Publicado: (2017)

Management of Infantile Hemangiomas: Current Trends
por: Sethuraman, Gomathy, et al.
Publicado: (2014)

Low-dose sclerotherapy with lauromacrogol in the treatment of infantile hemangiomas: A retrospective analysis of 368 cases
por: Wang, Changfeng, et al.
Publicado: (2022)

Signaling pathways in the development of infantile hemangioma
por: Ji, Yi, et al.
Publicado: (2014)

Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012)

Biology of Infantile Hemangioma
por: Itinteang, Tinte, et al.
Publicado: (2014)

Approach to Infantile Hemangiomas
por: Abraham, Anil, et al.
Publicado: (2016)

Infantile Periocular Hemangioma
por: Tavakoli, Mehdi, et al.
Publicado: (2017)

Update on infantile hemangioma
por: Jung, Hye Lim
Publicado: (2021)

Surgical management of large scalp infantile hemangiomas
por: Khan, Imad S., et al.
Publicado: (2014)

Propranolol-induced hyperkalemia in the management of infantile hemangioma
por: Al-Rwebah, Huda, et al.
Publicado: (2020)

Infantile hemangioma models: is the needle in a haystack?
por: Kong, Meng, et al.
Publicado: (2023)

Infantile hepatic hemangiomas: looking backwards and forwards
por: Gong, Xue, et al.
Publicado: (2022)

Propranolol therapy for infantile hemangioma: our experience
por: Zhang, Ling, et al.
Publicado: (2017)

CD146(+) mural cells from infantile hemangioma display proangiogenic ability and adipogenesis potential in vitro and in xenograft models
por: Chen, Jialin, et al.
Publicado: (2023)

Management of infantile subglottic hemangioma with T-tube placement and propranolol
por: D’Ambrosio, Paula Duarte, et al.
Publicado: (2022)

Role of connexins in infantile hemangiomas
por: Blanke, Katja, et al.
Publicado: (2013)

Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013)

Sclerotherapy for the Treatment of Infantile Hemangiomas
por: Grover, Chander, et al.
Publicado: (2012)

Propranolol in the Treatment of Infantile Hemangiomas
por: Tan, Xin, et al.
Publicado: (2021)

Our experience with propranolol for infantile hemangioma
por: Wu, Yao, et al.
Publicado: (2023)

Case report: Deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: Three cases reports
por: Chen, Qiang, et al.
Publicado: (2022)

A survey on the application of oral propranolol and atenolol for the management of infantile hemangiomas in mainland China: Survey on propranolol atenolol hemangiomas
por: Zhao, Ze-Liang, et al.
Publicado: (2021)

Congenital Myofibroma Mimicking an Infantile Hemangioma in an Infant
por: Han, Ji Su, et al.
Publicado: (2014)

Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study
por: Ge, Jing, et al.
Publicado: (2016)

Corrigendum: Case report: deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: three cases reports
por: Chen, Qiang, et al.
Publicado: (2023)

Estrogen-mediated hemangioma-derived stem cells through estrogen receptor-α for infantile hemangioma
por: Zhang, Ling, et al.
Publicado: (2017)

A premonitory mark of segmental infantile hemangioma
por: Hung, Yi-Teng, et al.
Publicado: (2022)

Effectiveness and Safety of Oral Propranolol versus Other Treatments for Infantile Hemangiomas: A Meta-Analysis
por: Liu, Xiaohan, et al.
Publicado: (2015)

Clinical Features of Segmental Infantile Hemangioma: A Prospective Study
por: Qiu, Tong, et al.
Publicado: (2021)

Infantile Hemangioma: A Brief Review
por: BOTA, MADALINA, et al.
Publicado: (2015)

Mechanisms of propranolol action in infantile hemangioma
por: Kum, Jina JY, et al.
Publicado: (2015)

When to stop propranolol for infantile hemangioma
por: Chang, Lei, et al.
Publicado: (2017)

Infantile hemangioma: timely diagnosis and treatment
por: Park, Meerim
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_379sensdq5tlb0e8mk8bbveajg